Bionano Genomics (STU:2Y30) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:2Y30 Bionano Genomics Inc STU:2Y30
64 GF Score
Price €315.84
GF Value €422.95
! 3 Warning Signs
View Full Analysis

What is Bionano Genomics Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:2Y30 vs UEEC, CUPR, FEMY: Short Interest Comparison

For the Medical Instruments & Supplies subindustry, Bionano Genomics's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionano Genomics Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bionano Genomics's Short Interest distribution charts can be found below:

* The bar in red indicates where Bionano Genomics's Short Interest falls into.


STU:2Y30
64GF Score
Bionano Genomics Inc STU:2Y30
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bionano Genomics (STU:2Y30) Overvalued in 2026?

Based on GuruFocus' analysis, Bionano Genomics stock appears to be undervalued. The current stock price of €315.84 is trading 25.3% below its estimated GF Value™ of €422.95.

Key valuation signals for STU:2Y30:

  • Short Interest:
  • GF Value™: €422.95 vs. price of €315.84 (25.3% below fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the STU:2Y30 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bionano Genomics Business Description

Other Exchanges BNGO:USABNGO:Mexico
Address 9540 Towne Centre Drive, Suite 100, San Diego, CA, USA, 92121
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
64GF Score

Get the complete analysis for STU:2Y30

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€315.84
Price
€422.95
GF Value